![Dépression résistante : SPRAVATO, nouvel antidépresseur à base d'eskétamine en solution pour pulvérisation nasale Dépression résistante : SPRAVATO, nouvel antidépresseur à base d'eskétamine en solution pour pulvérisation nasale](http://vidalactus.vidal.fr/gestionnaire/_images/mediatheque/Capturedecran2020-10-08a15.16.40.png)
Dépression résistante : SPRAVATO, nouvel antidépresseur à base d'eskétamine en solution pour pulvérisation nasale
![New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - ketamine.news New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - ketamine.news](https://ketamine.news/wp-content/uploads/2020/08/Spravato-_-Sandhya-Prashad-MD-social-post-1.png)
New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D. - ketamine.news
![J&J depression spray Spravato, carrying big expectations and restrictions, scores FDA nod | Fierce Pharma J&J depression spray Spravato, carrying big expectations and restrictions, scores FDA nod | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1551886134/spravato.jpg?VersionId=1w_nLNSPD91igaX5OW4fYvbUVZY3kvgn)
J&J depression spray Spravato, carrying big expectations and restrictions, scores FDA nod | Fierce Pharma
![These highlights do not include all the information needed to use SPRAVATO ®safely and effectively. See full prescribing information for SPRAVATO ®. SPRAVATO ®(esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine) These highlights do not include all the information needed to use SPRAVATO ®safely and effectively. See full prescribing information for SPRAVATO ®. SPRAVATO ®(esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=spravato-01.jpg&id=739792)